Form D · Pharmaceuticals
Innovative Med Concepts, LLC
Tuscaloosa, AL · CIK 0001547539
Offering snapshot reported Aug 24, 2020 · SEC filing
- Reported sold
- $125K Offering amount: $2.13M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 21, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2020 | Initial | $125,000 | No comparison | 5 | SEC filing |
| Aug 4, 2020 | Initial | $0 | No comparison | 59 | SEC filing |
| Apr 15, 2020 | Initial | $1,162,500 | No comparison | 20 | SEC filing |
| Jan 28, 2019 | Initial | $925,000 | No comparison | 10 | SEC filing |
| Mar 28, 2018 | Initial | $1,025,000 | No comparison | 14 | SEC filing |
| Mar 31, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 10, 2013 | Amendment | $3,085,000 | $395,000vs Sep 25, 2013 | 75 | SEC filing |
| Sep 25, 2013 | Amendment | $2,690,000 | $2,080,000vs May 16, 2012 | 69 | SEC filing |
| May 16, 2012 | Amendment | $610,000 | $390,000vs Apr 23, 2012 | 27 | SEC filing |
| Apr 23, 2012 | Initial | $220,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373906
No sales commissions or finders' fees will be paid in connection with this offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Aug 24, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Burch | Executive, Promoter |
| Greg Duncan | Director, Executive, Promoter |
| Ian Ferrier | Promoter |
| William Pridgen | Director, Executive, Promoter |
| William L Pridgen, M.D. | Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1837 Commons North Drive
Tuscaloosa, AL, 35406
Tuscaloosa, AL, 35406